Skip to main content
EnglishEN

Development of GPER agonists as a novel therapeutic option for pancreatic cancer

Project description

DEENESFRITPL

A new therapy could change the outcome for millions with pancreatic cancer

Fields of science

Programme(s)

Topic(s)

Call for proposal

ERC-2019-PoC

See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Net EU contribution
€ 150 000,00
Address
South Kensington Campus Exhibition Road
SW7 2AZ London
United Kingdom

See on map

Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Links
Other funding
No data

Beneficiaries (1)

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom
Net EU contribution
€ 150 000,00
Address
South Kensington Campus Exhibition Road
SW7 2AZ London

See on map

Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Links
Other funding
No data

Share this page

Download

EC signature date: 2 August 2019
Last update: 15 September 2022
Record number: 224615

My Booklet

Permalink: https://cordis.europa.eu/project/id/874581

© European Union, 2023